This project seeks to identify and validate additional urinary biomarkers for colorectal cancer and precancerous polyps to improve the performance of a colorectal cancer screening test.
Metabolomic Technologies Inc.
7 records totalling $876,781.00 CAD, from official Government of Canada open data.
Embed this chart
By department
| National Research Council Canada | $876,781 | 7 records |
Records
Metabolomic Technologies Inc.
$356,490.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
FY 2021-2022
Canada
METABOLOMIC TECHNOLOGIES INC.
$264,500.00
National Research Council Canada | Conseil national de recherches Canada
FY 2013-2014
Canada
METABOLOMIC TECHNOLOGIES INC.
$66,995.00
National Research Council Canada | Conseil national de recherches Canada
FY 2011-2012
Canada
Metabolomic Technologies Inc.
$60,880.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Innovation Assistance Program
FY 2020-2021
Canada
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
Metabolomic Technologies Inc.
$50,820.00
National Research Council Canada | Conseil national de recherches Canada
Innovation Assistance Program
FY 2020-2021
Canada
The funding provided from the IAP program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
METABOLOMIC TECHNOLOGIES INC.
$50,000.00
National Research Council Canada | Conseil national de recherches Canada
FY 2016-2017
Canada
Metabolomic Technologies Inc.
$27,096.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Innovation Assistance Program
FY 2020-2021
Canada
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.